Hilde Windels
Vorsitzender bei CELYAD ONCOLOGY SA
Vermögen: - $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Hilde Windels
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Katholieke Universiteit Leuven
44
| College/University | Other Consumer Services | 44 |
| Public Company | Biotechnology | 29 | |
| Public Company | Medical Specialties | 19 | |
18
| Public Company | Investment Managers | 18 |
17
| Public Company | Medical Specialties | 17 |
| Public Company | Pharmaceuticals: Major | 16 | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium.
14
| Subsidiary | Biotechnology | 14 |
12
| Subsidiary | Biotechnology | 12 |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium.
9
| Holding Company | Biotechnology | 9 |
Antelope Dx BV
 Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019.
8
| Private Company | Packaged Software | 8 |
Microphyt SA
 Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France.
6
| Holding Company | Biotechnology | 6 |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.
2
| College/University | Other Consumer Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hilde Windels
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Ghent University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of Antwerp | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Vlerick Leuven Gent Management School | College/University | Graduate Degree Masters Business Admin Director of Finance/CFO Graduate Degree Masters Business Admin Masters Business Admin | |
Biocartis NV
 Biocartis NV Internet Software/ServicesTechnology Services Part of Biocartis Group NV, Biocartis NV is a Belgian molecular diagnostics company that aims to revolutionize the field with its proprietary IdyllaTM platform. The company is based in Mechelen, Belgium, and the CEO of the company is Herman Verrelst. The company provides next-generation diagnostic solutions with a focus on improving clinical practice in oncology for the benefit of patients, clinicians, payers, and the healthcare industry. | Internet Software/Services | Director/Board Member Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
| BIOTALYS NV | Chemicals: Agricultural | Director/Board Member Chairman Director/Board Member Director/Board Member | |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
Gimv (Private Equity)
 Gimv (Private Equity) Investment ManagersFinance Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium. | Investment Managers | Chief Executive Officer Private Equity Analyst Director of Finance/CFO | |
| UCB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| Agentschap Vlaamse Sociale Bescherming | Director/Board Member Director/Board Member Director/Board Member | ||
KBC Securities NV
 KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors. | Investment Banks/Brokers | Corporate Officer/Principal Director of Research - Equity Chairman | |
| MedPole SA/NV | Chief Executive Officer Chief Operating Officer Director of Finance/CFO | ||
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Founder President Corporate Officer/Principal | |
| QUEST FOR GROWTH NV | Investment Managers | Director/Board Member Director/Board Member Director/Board Member | |
Participatiemaatschappij Vlaanderen NV
 Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor Director/Board Member Private Equity Investor | |
| Yale University | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree | |
Adviesbeheer Gimv Health & Care 2016 NV
 Adviesbeheer Gimv Health & Care 2016 NV Financial ConglomeratesFinance Adviesbeheer Gimv Health & Care 2016 NV is an investment holding Belgian company that provides management, investment, real estate, and public relation services. The company was founded in 2016 and is based in Antwerp, Belgium. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
| Université Catholique de Louvain | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
Ionix Pharmaceuticals Ltd.
 Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ionix Pharmaceuticals Ltd. used to develop analgesic medicines for the treatment of acute and chronic pain. Its drugs were used for the treatment of pain associated with chronic debilitating diseases such as osteoarthritis, diabetes, cancer and multiple sclerosis. The company was founded by Andrew Sandham, Phillip J. Birch, John Wood and Ann Gail Hayes in 2001 and was located in Cambridge, UK. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
KBC Asset Management NV
 KBC Asset Management NV Investment ManagersFinance KBC Asset Management NV (KBC AM) is the wholly-owned asset management subsidiary of KBC Bank NV, itself a subsidiary of KBC Group SA/NV (XB: KBC; ADR: KBCSY) in Belgium. The firm was founded in 2000 and is previously a division of KBC Bank. Headquartered in Brussels, KBC AM provides asset management services to private individuals, corporate clients and institutions. They also manage a range of mutual funds across various asset classes, markets and strategies. | Investment Managers | Head-Equity Investments Chairman | |
| AVANTIUM N.V. | Industrial Machinery | Chairman Director/Board Member | |
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BARCO NV | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| University of Lyon | College/University | Doctorate Degree Doctorate Degree | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| AGFA-GEVAERT NV | Electronics/Appliances | Director/Board Member Director/Board Member | |
I-mmoPad NV
 I-mmoPad NV Financial ConglomeratesFinance Part of Gimv NV, I-mmoPad NV is an investment holding Belgian company. The company is based in Antwerpe, Belgium. Founded in 1981, I-mmoPad functions as an investment holding company. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Avantium Technologies BV
 Avantium Technologies BV Miscellaneous Commercial ServicesCommercial Services Avantium Technologies BV operates as chemical technology company. It offers a breeding ground for revolutionary renewable chemistry solutions. The firm specializes in innovations and technologies for catalytic research and development services and systems. The company was founded in February 2000 and is headquartered in Amsterdam, the Netherlands | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Chief Operating Officer Corporate Officer/Principal | |
VPM SA
 VPM SA Marine ShippingTransportation Part of TUI AG, VPM SA is a company based in Villejuif, France. The French company's website is www.vpm.fr. VPM was acquired by Bestsail AG from Groupe Nouvelles Frontières SAS on April 05, 2002. | Marine Shipping | Director/Board Member Director/Board Member | |
| TIGENIX NV | Medical Specialties | Founder Corporate Officer/Principal | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Masters Business Admin | |
| ONTEX GROUP NV | Household/Personal Care | Chairman Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Pacira CryoTech, Inc.
 Pacira CryoTech, Inc. Medical/Nursing ServicesHealth Services Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
American Association for Clinical Chemistry, Inc.
 American Association for Clinical Chemistry, Inc. Medical/Nursing ServicesHealth Services American Association for Clinical Chemistry, Inc. (AACC) is a scientific and medical professional organization that focuses on clinical laboratory science and its application to healthcare. The organization is based in Washington and was founded in 1948. AACC provides leadership in education, advocacy, and collaboration to help lab professionals adapt to change and provide vital insight and guidance for patient care. The organization offers accreditation programs, press releases, media advisories, and statements that spotlight scientific, clinical, and technological breakthroughs. AACC has a longstanding commitment to provide customers with the best possible experience every time they use the AACC website. Mark J. Golden has been the CEO of the American company since 2020. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
Puilaetco Dewaay Private Bankers SA
 Puilaetco Dewaay Private Bankers SA Investment ManagersFinance Puilaetco Dewaay Private Bankers SA (PDPB) is the wholly-owned Belgian private banking subsidiary of KBL European Private Bankers SA, itself a subsidiary of Precision Capital SA in Luxembourg. Created in 2005, the firm is located in Brussels with offices in Antwerp, Knokke and Liège. They provide private banking and asset management services to institutions, corporate clients, high-net worth private individuals and family offices. | Investment Managers | Portfolio Manager-Equities Director/Board Member | |
Ecorys BV
 Ecorys BV Miscellaneous Commercial ServicesCommercial Services Ecorys BV is an international research and Dutch consultancy company that aims to make a positive impact on society by addressing key challenges in various sectors such as social policy, health, education, and environment. Ecorys is based in Rotterdam, Netherlands, and has subsidiaries in the Netherlands. The private company provides qualitative and quantitative research, policy formulation, strategy development, and technical assistance services to help clients make informed decisions. Manon Janssen has been the CEO of the company since 2010. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree | |
| GREENYARD NV | Food: Specialty/Candy | Chairman Director/Board Member | |
JenaValve Technology, Inc.
 JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member Director/Board Member | |
| The University of Sheffield | College/University | Doctorate Degree Undergraduate Degree |
Statistik
International
| Belgien | 26 |
| Vereinigte Staaten | 9 |
| Frankreich | 8 |
| Niederlande | 5 |
| Schweiz | 4 |
Sektoral
| Health Technology | 17 |
| Consumer Services | 12 |
| Finance | 9 |
| Health Services | 4 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 573 |
| Corporate Officer/Principal | 170 |
| Independent Dir/Board Member | 136 |
| Chairman | 131 |
| Chief Executive Officer | 106 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Koen Dejonckheere | 46 |
| Edwin Moses | 35 |
| Bo Jesper Hansen | 34 |
| Ann-Christine Sundell | 33 |
| Rudi Mariën | 31 |
| Catherine Moukheibir | 29 |
| Brigitte Boone | 29 |
| Donnie Hardison | 27 |
| Eric Jean Marie Leire | 27 |
| Roald Borré | 25 |
| Didier Hoch | 24 |
| Philippe Archinard | 24 |
| Peter John Fellner | 21 |
| Serge Goblet | 20 |
| Chang Qi Wu | 20 |
- Börse
- Insiders
- Hilde Windels
- Unternehmensverbindungen